Patents by Inventor Ormond A. MacDougald

Ormond A. MacDougald has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GSK-3 INHIBITORS
    Publication number: 20090074886
    Abstract: This invention relates to methods of treating or preventing bone loss by administering to a human or animal subject pyrimidine and pyridine derivatives that inhibit the activity of glycogen synthase kinase 3 (GSK3), to pharmaceutical compositions containing the compounds, and to the use of the compounds and compositions alone or in combination with other pharmaceutically active agents.
    Type: Application
    Filed: December 1, 2008
    Publication date: March 19, 2009
    Inventors: Christina N. Bennett, Kurt D. Hankenson, Stephen D. Harrison, Kenneth A. Longo, Ormond A. MacDougald, Allan S. Wagman
  • Compositions and methods for characterizing and regulating Wnt pathways
    Patent number: 7135611
    Abstract: The present invention relates to transgenic animal models for altered Wnt expression. The present invention also provides methods for generating animal models and screening methods for identifying biologically active compounds.
    Type: Grant
    Filed: January 12, 2004
    Date of Patent: November 14, 2006
    Assignee: Regents of the University of Michigan
    Inventors: Ormond A. MacDougald, Kenneth A. Longo, Sarah E. Ross
  • GSK-3 inhibitors
    Publication number: 20050054663
    Abstract: This invention relates to methods of treating or preventing bone loss by administering to a human or animal subject pyrimidine and pyridine derivatives that inhibit the activity of glycogen synthase kinase 3 (GSK3), to pharmaceutical compositions containing the compounds, and to the use of the compounds and compositions alone or in combination with other pharmaceutically active agents.
    Type: Application
    Filed: August 13, 2004
    Publication date: March 10, 2005
    Inventors: Christina Bennett, Kurt Hankenson, Stephen Harrison, Kenneth Longo, Ormond MacDougald, Allan Wagman
  • Compositions and methods for characterizing and regulating Wnt pathways
    Publication number: 20040216176
    Abstract: The present invention relates to transgenic animal models for altered Wnt expression. The present invention also provides methods for generating animal models and screening methods for identifying biologically active compounds.
    Type: Application
    Filed: January 12, 2004
    Publication date: October 28, 2004
    Applicant: The Regents of the University of Michigan
    Inventors: Ormond A. MacDougald, Kenneth A. Longo, Sarah E. Ross